Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer’s disease

Science Advances

Volumn 3, Issue 2, 2017, Pages

  Hamm, Valentine ^a,b   Héraud, Céline ^a,b   Bott, Jean Bastien ^a,b   Herbeaux, Karine ^a,b   Strittmatter, Carole ^a,b   Mathis, Chantal ^a,b   Goutagny, Romain ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Université de Strasbourg Faculté de Psychologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; NEURAL NETWORKS; NEURODEGENERATIVE DISEASES; NEURONS; PATHOLOGY;

COGNITIVE DEFICITS; COGNITIVE FUNCTIONS; DIFFERENTIAL CONTRIBUTION; MEMORY CAPACITY; NEURODEGENERATIVE; NEURONAL DAMAGE; NEURONAL NETWORKS; YOUNG ADULTS;

MAMMALS;

AMYLOID BETA PROTEIN; PARVALBUMIN; PROTEIN C FOS; SECRETASE; SOMATOSTATIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CHEMISTRY; COGNITIVE DEFECT; DISEASE MODEL; GENETICS; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; MOUSE; PATHOLOGY; SHORT TERM MEMORY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BEHAVIOR, ANIMAL; COGNITIVE DYSFUNCTION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MALE; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PARVALBUMINS; PROTO-ONCOGENE PROTEINS C-FOS; SOMATOSTATIN;

EID: 85028573878     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1601068     Document Type: Article

References (62)

1. D. J. Selkoe, Toward a comprehensive theory for Alzheimer’s disease. Hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid b-protein. Ann. N. Y. Acad. Sci. 924, 17–25 (2000).
2. J. J. Palop, L. Mucke, Amyloid-b–induced neuronal dysfunction in Alzheimer’s disease: From synapses toward neural networks. Nat. Neurosci. 13, 812–818 (2010).
3. C. Haass, D. J. Selkoe, Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid b-peptide. Nat. Rev. Mol. Cell Biol. 8, 101–112 (2007).
4. 42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
5. D. J. Selkoe, The molecular pathology of Alzheimer’s disease. Neuron 6, 487–498 (1991).
6. J. A. Mikulca, V. Nguyen, D. A. Gajdosik, S. G. Teklu, E. A. Giunta, E. A. Lessa, C. H. Tran, E. C. Terak, R. B. Raffa, Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches. J. Clin. Pharm. Ther. 39, 25–37 (2014).
7. S. W. Pimplikar, Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int. J. Biochem. Cell Biol. 41, 1261–1268 (2009).
8. T. E. Golde, L. S. Schneider, E. H. Koo, Anti-ab therapeutics in Alzheimer’s disease: The need for a paradigm shift. Neuron 69, 203–213 (2011).
9. R. Goutagny, N. Gu, C. Cavanagh, J. Jackson, J.-G. Chabot, R. Quirion, S. Krantic, S. Williams, Alterations in hippocampal network oscillations and theta-gamma coupling arise before Ab overproduction in a mouse model of Alzheimer’s disease. Eur. J. Neurosci. 37, 1896–1902 (2013).
10. I. Lauritzen, R. Pardossi-Piquard, C. Bauer, E. Brigham, J.-D. Abraham, S. Ranaldi, P. Fraser, P. St-George-Hyslop, O. Le Thuc, V. Espin, L. Chami, J. Dunys, F. Checler, The b-secretase-derived C-terminal fragment of bAPP, C99, but not Ab, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J. Neurosci. 32, 16243–16255 (2012).
11. K.-A. Chang, Y.-H. Suh, Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the b-amyloid precursor protein in Alzheimer’s disease. J. Pharmacol. Sci. 97, 461–471 (2005).
12. Y. Mitani, J. Yarimizu, K. Saita, H. Uchino, H. Akashiba, Y. Shitaka, K. Ni, N. Matsuoka, Differential effects between g-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J. Neurosci. 32, 2037–2050 (2012).
13. R. L. Neve, F. M. Boyce, D. L. McPhie, J. Greenan, M. L. Oster-Granite, Transgenic mice expressing APP-C100 in the brain. Neurobiol. Aging 17, 191–203 (1996).
14. R. Tamayev, L. D’Adamio, Inhibition of g-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia. Mol. Neurodegener. 7, 19 (2012).
15. R. Tamayev, S. Matsuda, O. Arancio, L. D’Adamio, b- but not g-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol. Med. 4, 171–179 (2012).
16. D. L. Vogt, sD. Thomas, V. Galvan, D. E. Bredesen, B. T. Lamb, S. W. Pimplikar, Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol. Aging 32, 1725–1729 (2011).
17. M. Willem, S. Tahirovic, M. A. Busche, S. V. Ovsepian, M. Chafai, S. Kootar, D. Hornburg, L. D. B. Evans, S. Moore, A. Daria, H. Hampel, V. Müller, C. Giudici, B. Nuscher, A. Wenninger-Weinzierl, E. Kremmer, M. T. Heneka, D. R. Thal, V. Giedraitis, L. Lannfelt, U. Müller, F. J. Livesey, F. Meissner, J. Herms, A. Konnerth, H. Marie, C. Haass, h-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526, 443–447 (2015).
18. M. Didic, E. J. Barbeau, O. Felician, E. Tramoni, E. Guedj, M. Poncet, M. Ceccaldi, Which memory system is impaired first in Alzheimer’s disease? J. Alzheimers Dis. 27, 11–22 (2011).
19. K. Vlček, Spatial navigation impairment in healthy aging and Alzheimer’s disease, in The Clinical Spectrum of Alzheimer’s Disease–The Charge Toward Comprehensive Diagnostic and Therapeutic Strategies, S. De La Monte, Ed. (InTech, ed. 5, 2011).
20. J. Hort, J. Laczó, M. Vyhnálek, M. Bojar, J. Bureš, K. Vlček, Spatial navigation deficit in amnestic mild cognitive impairment. Proc. Natl. Acad. Sci. U.S.A. 104, 4042–4047 (2007).
21. K. E. Ameen-Ali, A. Easton, M. J. Eacott, Moving beyond standard procedures to assess spontaneous recognition memory. Neurosci. Biobehav. Rev. 53, 37–51 (2015).
22. M. A. Chishti, D.-S. Yang, C. Janus, A. L. Phinney, P. Horne, J. Pearson, R. Strome, N. Zuker, J. Loukides, J. French, S. Turner, G. Lozza, M. Grilli, S. Kunicki, C. Morissette, J. Paquette, F. Gervais, C. Bergeron, P. E. Fraser, G. A. Carlson, P. St. George-Hyslop, D. Westaway, Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 21562–21570 (2001).
23. C. Cavanagh, J. Colby-Milley, D. Bouvier, M. Farso, J.-G. Chabot, R. Quirion, S. Krantic, bCTF-correlated burst of hippocampal TNFa occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer’s disease. J. Alzheimers Dis. 36, 233–238 (2013).
24. V. S. Sohal, F. Zhang, O. Yizhar, K. Deisseroth, Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698–702 (2009).
25. T. Dugladze, I. Vida, A. B. Tort, A. Gross, J. Otahal, U. Heinemann, N. J. Kopell, T. Gloveli, Impaired hippocampal rhythmogenesis in a mouse model of mesial temporal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 104, 17530–17535 (2007).
26. L. Verret, E. O. Mann, G. B. Hang, A. M. I. Barth, I. Cobos, K. Ho, N. Devidze, E. Masliah, A. C. Kreitzer, I. Mody, L. Mucke, J. J. Palop, Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708–721 (2012).
27. L. C. Schmid, M. Mittag, S. Poll, J. Steffen, J. Wagner, H.-R. Geis, I. Schwarz, B. Schmidt, M. K. Schwarz, S. Remy, M. Fuhrmann, Dysfunction of somatostatin-positive interneurons associated with memory deficits in an Alzheimer’s disease model. Neuron 92, 114–125 (2016).
28. S. N. Burke, A. P. Maurer, S. Nematollahi, A. R. Uprety, J. L. Wallace, C. A. Barnes, The influence of objects on place field expression and size in distal hippocampal CA1. Hippocampus 21, 783–801 (2011).
29. F. L. Assini, M. Duzzioni, R. N. Takahashi, Object location memory in mice: Pharmacological validation and further evidence of hippocampal CA1 participation. Behav. Brain Res. 204, 206–211 (2009).
30. N. J. Goodrich-Hunsaker, M. R. Hunsaker, R. P. Kesner, The interactions and dissociations of the dorsal hippocampus subregions: How the dentate gyrus, CA3, and CA1 process spatial information. Behav. Neurosci. 122, 16–26 (2008).
31. C. A. Barnes, Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74–104 (1979).
32. P. C. May, R. A. Dean, S. L. Lowe, F. Martenyi, S. M. Sheehan, L. N. Boggs, S. A. Monk, B. M. Mathes, D. J. Mergott, B. M. Watson, S. L. Stout, D. E. Timm, E. Smith Labell, C. R. Gonzales, M. Nakano, S. S. Jhee, M. Yen, L. Ereshefsky, T. D. Lindstrom, D. O. Calligaro, P. J. Cocke, D. Greg Hall, S. Friedrich, M. Citron, J. E. Audia, Robust central reduction of amyloid-b in humans with an orally available, non-peptidic b-secretase inhibitor. J. Neurosci. 31, 16507–16516 (2011).
33. D. I. G. Wilson, S. Watanabe, H. Milner, J. A. Ainge, Lateral entorhinal cortex is necessary for associative but not nonassociative recognition memory. Hippocampus 23, 1280–1290 (2013).
34. A. Nordberg, Dementia in 2014: Towards early diagnosis in Alzheimer disease. Nat. Rev. Neurol. 11, 69–70 (2015).
35. S. Krantic, N. Isorce, N. Mechawar, M. A. Davoli, E. Vignault, M. Albuquerque, J.-G. Chabot, E. Moyse, J.-P. Chauvin, I. Aubert, J. McLaurin, R. Quirion, Hippocampal GABAergic neurons are susceptible to amyloid-b toxicity in vitro and are decreased in number in the Alzheimer’s disease TgCRND8 mouse model. J. Alzheimers Dis. 29, 293–308 (2012).
36. D. Lapray, B. Lasztoczi, M. Lagler, T. J. Viney, L. Katona, O. Valenti, K. Hartwich, Z. Borhegyi, P. Somogyi, T. Klausberger, Behavior-dependent specialization of identified hippocampal interneurons. Nat. Neurosci. 15, 1265–1271 (2012).
37. C. Varga, P. Golshani, I. Soltesz, Frequency-invariant temporal ordering of interneuronal discharges during hippocampal oscillations in awake mice. Proc. Natl. Acad. Sci. U.S.A. 109, E2726–E2734 (2012).
38. M. S. Albuquerque, I. Mahar, M. A. Davoli, J.-G. Chabot, N. Mechawar, R. Quirion, S. Krantic, Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer’s disease. Front. Aging Neurosci. 7, 30 (2015).
39. B. M. Francis, J. Kim, M. E. Barakat, S. Fraenkl, Y. H. Yücel, S. Peng, B. Michalski, M. Fahnestock, J. McLaurin, H. T. J. Mount, Object recognition memory and BDNF expression are reduced in young TgCRND8 mice. Neurobiol. Aging 33, 555–563 (2012).
40. C. Janus, J. Pearson, J. McLaurin, P. M. Mathews, Y. Jiang, S. D. Schmidt, M. A. Chishti, P. Horne, D. Heslin, J. French, H. T. J. Mount, R. A. Nixon, M. Mercken, C. Bergeron, P. E. Fraser, P. St George-Hyslop, D. Westaway, Ab peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature 408, 979–982 (2000).
41. A. Assini, S. Cammarata, A. Vitali, M. Colucci, L. Giliberto, R. Borghi, M. L. Inglese, S. Volpe, S. Ratto, F. Dagna-Bricarelli, C. Baldo, A. Argusti, P. Odetti, A. Piccini, M. Tabaton, Plasma levels of amyloid b-protein 42 are increased in women with mild cognitive impairment. Neurology 63, 828–831 (2004).
42. K. Irvine, K. R. Laws, T. M. Gale, T. K. Kondel, Greater cognitive deterioration in women than men with Alzheimer’s disease: A meta analysis. J. Clin. Exp. Neuropsychol. 34, 989–998 (2012).
43. S. A. Shumaker, C. Legault, S. R. Rapp, L. Thal, R. B. Wallace, J. K. Ockene, S. L. Hendrix, B. N. Jones III, A. R. Assaf, R. D. Jackson, J. M. Kotchen, S. Wassertheil-Smoller, J. Wactawski-Wende; WHIMS Investigators, Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: A randomized controlled trial. JAMA 289, 2651–2662 (2003).
44. A. J. Murray, J.-F. Sauer, G. Riedel, C. McClure, L. Ansel, L. Cheyne, M. Bartos, W. Wisden, P. Wulff, Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat. Neurosci. 14, 297–299 (2011).
45. C. Ripoli, S. Cocco, D. D. Li Puma, R. Piacentini, A. Mastrodonato, F. Scala, D. Puzzo, M. D’Ascenzo, C. Grassi, Intracellular accumulation of amyloid-b (Ab) protein plays a major role in Ab-induced alterations of glutamatergic synaptic transmission and plasticity. J. Neurosci. 34, 12893–12903 (2014).
46. E. C. Fuchs, A. R. Zivkovic, M. O. Cunningham, S. Middleton, F. E. N. Lebeau, D. M. Bannerman, A. Rozov, M. A. Whittington, R. D. Traub, J. N. P. Rawlins, H. Monyer, Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53, 591–604 (2007).
47. T. Korotkova, E. C. Fuchs, A. Ponomarenko, J. von Engelhardt, H. Monyer, NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68, 557–569 (2010).
48. H. Meziane, J.-C. Dodart, C. Mathis, S. Little, J. Clemens, S. M. Paul, A. Ungerer, Memory-enhancing effects of secreted forms of the b-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U.S.A. 95, 12683–12688 (1998).
49. 695) improves spatial recognition memory in OF1 mice. Neurobiol. Learn. Mem. 81, 27–38 (2004).
50. R. Fol, J. Braudeau, S. Ludewig, T. Abel, S. W. Weyer, J.-P. Roederer, F. Brod, M. Audrain, A.-P. Bemelmans, C. J. Buchholz, M. Korte, N. Cartier, U. C. Müller, Viral gene transfer of APPsa rescues synaptic failure in an Alzheimer’s disease mouse model. Acta Neuropathol. 131, 247–266 (2016).
51. S. Chasseigneaux, B. Allinquant, Functions of Ab, sAPPa and sAPPb: Similarities and differences. J. Neurochem. 120 (suppl. 1), 99–108 (2012).
52. F. Biundo, K. Ishiwari, D. Del Prete, L. D’Adamio, Deletion of the g-secretase subunits Aph1B/C impairs memory and worsens the deficits of knock-in mice modeling the Alzheimer-like familial Danish dementia. Oncotarget 7, 11923–11944 (2016).
53. T. J. Bussey, J. Duck, J. L. Muir, J. P. Aggleton, Distinct patterns of behavioural impairments resulting from fornix transection or neurotoxic lesions of the perirhinal and postrhinal cortices in the rat. Behav. Brain Res. 111, 187–202 (2000).
54. D. G. Mumby, S. Gaskin, M. J. Glenn, T. E. Schramek, H. Lehmann, Hippocampal damage and exploratory preferences in rats: Memory for objects, places, and contexts. Learn. Mem. 9, 49–57 (2002).
55. D. I. G. Wilson, R. F. Langston, M. I. Schlesiger, M. Wagner, S. Watanabe, J. A. Ainge, Lateral entorhinal cortex is critical for novel object-context recognition. Hippocampus 23, 352–366 (2013).
56. E. Karran, J. Hardy, Antiamyloid therapy for Alzheimer’s disease—Are we on the right road? N. Engl. J. Med. 370, 377–378 (2014).
57. D. J. Selkoe, J. Hardy, The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 8, 595–608 (2016).
58. M. L. Hemming, J. E. Elias, S. P. Gygi, D. J. Selkoe, Identification of b-secretase (BACE1) substrates using quantitative proteomics. PLOS ONE 4, e8477 (2009).
59. H. Bokil, P. Andrews, J. E. Kulkarni, S. Mehta, P. P. Mitra, Chronux: A platform for analyzing neural signals. J. Neurosci. Methods 192, 146–151 (2010).
60. S. Pagliardini, S. Gosgnach, C. T. Dickson, Spontaneous sleep-like brain state alternations and breathing characteristics in urethane anesthetized mice. PLOS ONE 8, e70411 (2013).
61. I. Q. Whishaw, J.-A. Tomie, Of mice and mazes: Similarities between mice and rats on dry land but not water mazes. Physiol. Behav. 60, 1191–1197 (1996).
62. G. Ducharme, G. C. Lowe, R. Goutagny, S. Williams, Early alterations in hippocampal circuitry and theta rhythm generation in a mouse model of prenatal infection: Implications for schizophrenia. PLOS ONE 7, e29754 (2012).